MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12951-025-03100-y

Медицинская библиотека · Journal of nanobiotechnology · 2025

Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants.

Hwang Jaehyeon, Choi Soyun, Kim Beom Kyu, Son Sumin, Yoon Jeong Hyeon, Kim Kyung Won, Park Wonbeom, Choo Hyunjoo, Kim Suhyun, Kim Soomin, Yu Seokhyeon, Jung Sangwon, Jung Sang Taek, Song Min-Suk, Kim Sang Jick, Kweon Dae-Hyuk

СтатьяПеревод в очереди

Аннотация

Passive antibody therapies, typically administered via parenteral routes, have played a crucial role in the initial response to the COVID-19 pandemic. However, the ongoing evolution of SARS-CoV-2 has revealed significant limitations of this approach, primarily due to mutational escape and the inadequate delivery of antibodies to the upper respiratory tract. To overcome these challenges, we propose a novel prophylactic strategy involving the intranasal delivery of an antibody in combination with an Fc-binding nanodisc. This nanodisc, engineered to specifically bind to the Fc regions of IgG antibodies, served two key functions: extending the antibody's half-life in the larynx and trachea, and enhancing its neutralization efficacy. Notably, Sotrovimab, an FDA-approved monoclonal antibody that has experienced a significant decline in neutralizing potency due to viral evolution, exhibited robust antiviral activity when complexed with the nanodisc against all tested Omicron variants. Furthermore, the Fc-binding nanodisc significantly boosted the antiviral efficacy of the soluble angiotensin-converting enzyme 2 (sACE2) Fc fusion protein, which possesses broad but modest antiviral activity. In ACE2 transgenic mice, the Fc-binding nanodisc protected better than sACE2-Fc alone with two more log reduction in lung viral titer. Therefore, the intranasal Fc-binding nanodisc offers a promising and powerful approach to counteract the diminished antiviral activity of neutralizing antibodies caused by mutational escape, effectively restoring antiviral efficacy against various evolving SARS-CoV-2 variants.

Для цитирования: Hwang Jaehyeon, Choi Soyun, Kim Beom Kyu, Son Sumin, Yoon Jeong Hyeon, Kim Kyung Won, Park Wonbeom, Choo Hyunjoo, Kim Suhyun, Kim Soomin, Yu Seokhyeon, Jung Sangwon, Jung Sang Taek, Song Min-Suk, Kim Sang Jick, Kweon Dae-Hyuk. Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants.. Journal of nanobiotechnology. 2025. DOI: 10.1186/s12951-025-03100-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.